Boji Pharmaceuticals and its subsidiary reached a strategic partnership with European company Pharmaxi.

According to Boji Pharmaceuticals, recently, Boji Pharmaceuticals, together with its subsidiary BlOTrialMed, officially announced a strategic partnership with the European clinical research organization Pharmaxi. This three-party collaboration will deeply integrate Boji Pharmaceuticals' full-process research and development capabilities, BlOTrialMed's North American clinical service advantages, and Pharmaxi's European localization resources, providing Chinese biopharmaceutical companies with a "China-America-Europe" cross-regional clinical trial one-stop solution.